Luo Chunyan C - OmicsDI

Show results for

Proteomics (2)
Metabolomics (1)

Organisms

Arabidopsis thaliana (2)

Repository

iProX (2)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2022 (1)

CHEBI ID

CHEBI:183859 (1)
CHEBI:183857 (1)
CHEBI:182176 (1)
CHEBI:183851 (1)
CHEBI:82644 (1)
CHEBI:135975 (1)
CHEBI:183843 (1)
CHEBI:114204 (1)
CHEBI:183839 (1)
CHEBI:86228 (1)
CHEBI:46032 (1)
CHEBI:183829 (1)
CHEBI:31414 (1)
CHEBI:31441 (1)
CHEBI:183812 (1)
CHEBI:46582 (1)
CHEBI:183822 (1)
CHEBI:183820 (1)
CHEBI:183818 (1)
CHEBI:20553 (1)
CHEBI:8380 (1)
CHEBI:139411 (1)
CHEBI:182630 (1)
CHEBI:183858 (1)
CHEBI:183855 (1)
CHEBI:182627 (1)
CHEBI:83412 (1)
CHEBI:20140 (1)
CHEBI:58025 (1)
CHEBI:48623 (1)

Metabolite Name

(R)-(+)-Lactamide (1)
Dl-2-Hydroxybutyric acid (1)
3-Hydroxy-2-Methylbutanoic acid (1)
Dl-Homoserine (1)
2-Ketohexanoic acid /2-oxohexanoic acid (1)
Dl-Aspartic acid (1)
Dl-Malic acid (1)
2,2-Dimethylsuccinic Acid (1)
3-Carboxybenzadehyde (1)
3-Methylcrotonyl glycine (1)
3-(2-Hydroxyphenyl)-propionic acid (1)
Dl-4-Hydroxymandelic acid (1)
Dl-Norepinephrine (1)
D(-)-Arginine (1)
Dl-3,4-Dihydroxymandelic acid (1)
Theobromine-d6 (1)
2,6-Dichlorobenzoic Acid (1)
3-Nitrobenzene sulphonate (1)
Phenylthiouracil (1)
5-Hydroxy-thiabendazole (1)
7z,10z,13z-Hexadecatrienoic Acid (1)
Alpha-Glu-Leu (1)
4,4-Methylene-Bis(2-Chloroaniline) (1)
Hypoxanthine-9-alpha-D-arabinofuranoside (1)
O-Benzyl-L-tyrosine (1)
17-alpha-Ethinylestradiol (1)
Cis-10-Nonadecenoic acid (1)
Sulfachinoxalin /Sulfaquinoxaline (1)
N-[(Tert-butoxy)carbonyl]-L-tryptophan (1)
Cis-11,14-Eicosadienoic acid (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Acupuncture Synergized With Bortezomib Improves Survival of Multiple Myeloma Mice via Decreasing Metabolic Ornithine

Multiple myeloma (MM) is a hematological malignancy worldwide in urgent need for novel therapeutic strategies. Since Velcade (bortezomib) was approved for the treatment of relapsed/refractory MM in 2003, we have seen considerable improvement in extending MM patient survival. However, most patients a...

2022-02-21 | MTBLS3487 | MetaboLights

AtPRMT3-RPS2B promotes ribosome biogenesis and coordinates growth and cold adaptation trade-off _PDCD2-IP-MS

The associated proteins of PDCD2 identified by mass spectrograph

ORGANISM(S): Arabidopsis Thaliana

PXD055608 |

AtPRMT3-RPS2B promotes ribosome biogenesis and coordinates growth and cold adaptation trade-off _DIA MS

Quantitative MS analysis for nuclear proteins from Col-0, atprmt3-2, and suppressor m20.

ORGANISM(S): Arabidopsis Thaliana

PXD055607 |